Neurava

Neurava, **founded in 2019**, is an innovative player in the Health Care industry, with a focus on developing **wearable diagnostics for epilepsy patients** and those at risk of SUDEP (sudden unexpected death in epilepsy). The company's **slogan**, "Innovative diagnostics technology for managing epilepsy and reducing SUDEP risk," encapsulates its core mission. Neurava's expertise lies in **medical device manufacturing, healthcare, and health diagnostics**. In its latest funding round in **April 3, 2024**, the company secured an impressive **$2.26M** from a diverse group of investors including **Elevate Ventures, Life Science Angels, First Leaf Capital, Purdue Innovates Incubator, Rivermount Ventures, and Union Chimique Belge**. This significant investment signals confidence from multiple reputable investors in Neurava's promising diagnostic solutions, positioning the company for further growth and impact in the healthcare space.